tirzepatide surpass-4 Media Centre SURPASS-4 trial: Tirzepatide slows rate

As you reach your goal weight, the conversation naturally shifts from how much you can lose to how you will keep it off

Disposal of unused or expired medication should follow appropriate pharmaceutical waste disposal guidelines

Stopping should be a collaborative decision based on severity and impact on quality of life.

At 10 mg, it is one dose

Within each stratum (SURPASS-4 only and all other trials), baseline cardiovascular risk factors were well balanced among the pooled treatment groups (Supplementary Tables 6 and 7), although patients background of cardiovascular risk was different between strata (for example, 86.9% of participants for SURPASS-4 only and 10.6% of participants for all other trials had history of cardiovascular disease)

I personally know of 2 other women who started on semaglutide and got stalled and switched to tirzepatide and then were able to lose weight